Robust EEG Based Biomarkers to Detect Alzheimer’s Disease

Biomarkers to detect Alzheimer’s disease (AD) would enable patients to gain access to appropriate services and may facilitate the development of new therapies. Given the large numbers of people affected by AD, there is a need for a low-cost, easy to use method to detect AD patients. Potentially, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Nuaimi, Ali H., Blūma, Marina, Al-Juboori, Shaymaa S., Eke, Chima S., Jammeh, Emmanuel, Sun, Lingfen, Ifeachor, Emmanuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394244/
https://www.ncbi.nlm.nih.gov/pubmed/34439645
http://dx.doi.org/10.3390/brainsci11081026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394244/
https://www.ncbi.nlm.nih.gov/pubmed/34439645
http://dx.doi.org/10.3390/brainsci11081026

Ejemplares similares